Beating the odds: extreme long-term survival with glioblastoma
- PMID: 25096192
- PMCID: PMC4136904
- DOI: 10.1093/neuonc/nou166
Beating the odds: extreme long-term survival with glioblastoma
Comment on
- See the article by Gerber et al, on pages 1186–1195. doi: 10.1093/neuonc/nou043
References
-
- Johnson DR, Leeper HE, Uhm JH. Glioblastoma survival in the United States improved after Food and Drug Administration approval of bevacizumab: a population-based analysis. Cancer. 2013;119(19):3489–3495. - PubMed
-
- Chinot OL, Wick W, Mason W, et al. Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med. 2014;370(8):709–722. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
